Skip to main content

Blog

Letter to the FDA: Require Food Manufacturers to Post Substitutions

On May 22, 2020, the Food and Drug Administration (FDA) relaxed labeling guidelines for food companies . This is a temporary measure because of food supply issues due to COVID-19 (the new coronavirus). The Asthma and Allergy Foundation of America (AAFA) met with the FDA to talk about how this will affect the food allergy community. After the meeting, we organized a joint letter with other food allergy advocacy organizations to send to the FDA. The letter addresses the FDA’s short-term food...

Carry Your Emergency Medicines Everywhere You Go When You Have Asthma and Allergies

May is National Asthma and Allergy Awareness Month . The Asthma and Allergy Foundation of America (AAFA) and MedicAlert have teamed up to help you manage your asthma and allergies prevent life-threatening emergencies. Make a pact to “ACT” to manage your asthma and allergies: “A” means have an action plan for asthma or anaphylaxis . “C” reminds you to carry emergency medicines and wear a medical ID to alert others of your condition. “T” calls for having a treatment plan that includes when to...

What to Do If You Can't Afford Your Asthma Medicines

Keeping your asthma under control is a key part of staying healthy. Avoiding asthma triggers to prevent symptoms is important. So is carrying a quick-relief (rescue) inhaler everywhere you go. Long-term control medicines that you take every day help you prevent and control asthma symptoms. But asthma medicine can be expensive, whether or not you have insurance. If multiple members of your family have asthma, the cost is even greater. Your house may be stocked with different kinds of inhalers...

How an Action Plan Can Help You Treat Asthma and Allergic Reactions

May is National Asthma and Allergy Awareness Month . The Asthma and Allergy Foundation of America (AAFA) and MedicAlert have teamed up to help you manage your asthma and allergies prevent life-threatening emergencies. Make a pact to “ACT” to manage your asthma and allergies: “A” means have an action plan for asthma or anaphylaxis. “C” reminds you to carry emergency medicines and wear a medical ID to alert others of your condition. “T” calls for having a treatment plan that includes when to...

ACT for Asthma and Allergy: AAFA and MedicAlert Team Up for National Asthma and Allergy Awareness Month

More than 65 million people in the United States live with asthma or allergies to food , drugs or other allergens . About 3,600 people die each year from asthma – deaths that can often be prevented . COVID-19 (the new coronavirus) poses even more danger to people with asthma and allergies. To kick off National Asthma and Allergy Awareness Month and for World Asthma Day , the Asthma and Allergy Foundation of America (AAFA) and the MedicAlert Foundation have partnered to raise awareness and...

2020 Allergy Capitals™ Report: Seasonal Rankings by City for Spring and Fall

The Asthma and Allergy Foundation of America (AAFA) 2020 Allergy Capitals™ report is now available. This report ranks the top 100 most challenging cities in the continental United States to live in with seasonal allergies. AAFA combines data from both spring and fall to create a ranking of the top 100 cities based on: Pollen counts Allergy medicine use Number of board-certified allergists available The report also includes a breakdown of seasonal rankings of the top cities for both spring...

Dr. Philip Norman: An AAFA Tribute to an Allergy Legend

If you’ve ever benefited from immunotherapy (allergy shots, SLIT or oral immunotherapy), you can thank Dr. Philip Sidney Norman. Dr. Norman put allergy research on the map. He is known as the “father of modern immunotherapy for allergic disease” and even coined the term “allergen immunotherapy.” As an allergist and researcher for more than 50 years, he published 237 research papers and more than 100 book chapters and reviews. And for many decades, he was an important part of AAFA.

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut Allergy Treatments

The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.

Post
×
×
×
×